DOPAMINE HYDROCHLORIDE (DOPAMINE HYDROCHLORIDE) — FDA Approval ANDA072999 (TEVA PARENTERAL)
DOPAMINE HYDROCHLORIDE (DOPAMINE HYDROCHLORIDE) — FDA Approval ANDA072999 (TEVA PARENTERAL) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: DOPAMINE HYDROCHLORIDE; Active ingredients: DOPAMINE HYDROCHLORIDE; Application number: ANDA072999.
| Brand name | DOPAMINE HYDROCHLORIDE |
|---|---|
| Active ingredients | DOPAMINE HYDROCHLORIDE |
| Application number | ANDA072999 |
| Sponsor | TEVA PARENTERAL |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19911023 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →